Related references
Note: Only part of the references are listed.IFNγ signaling in cytotoxic T cells restricts anti-tumor responses by inhibiting the maintenance and diversity of intra-tumoral stem-like T cells
Julie M. Mazet et al.
NATURE COMMUNICATIONS (2023)
A high interferon gamma signature of CD8(+) T cells predicts response to neoadjuvant immunotherapy plus chemotherapy in gastric cancer
Sen Li et al.
FRONTIERS IN IMMUNOLOGY (2023)
Restraint of IFN-y expression through a distal silencer CNS-28 for tissue homeostasis
Kairong Cui et al.
IMMUNITY (2023)
Stepwise activities of mSWI/SNF family chromatin remodeling complexes direct T cell activation and exhaustion
Elena Battistello et al.
MOLECULAR CELL (2023)
RNF138 inhibits late inflammatory gene transcription through degradation of SMARCC1 of the SWI/SNF complex
Wei Liu et al.
CELL REPORTS (2023)
How cancer cells make and respond to interferon-I
HyeonJoo Cheon et al.
TRENDS IN CANCER (2023)
Reprogramming of nucleotide metabolism by interferon confers dependence on the replication stress response pathway in pancreatic cancer cells
Evan R. Abt et al.
CELL REPORTS (2022)
IL-6/IFN-gamma double knockdown CAR-T cells reduce the release of multiple cytokines from PBMCs in vitro
Huihui Zhang et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2022)
Central Role of the Antigen-Presentation and Interferon-γ Pathways in Resistance to Immune Checkpoint Blockade
Annette Paschen et al.
ANNUAL REVIEW OF CANCER BIOLOGY (2022)
IFNγ signaling integrity in colorectal cancer immunity and immunotherapy
Wan Du et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2022)
Type I interferon-mediated tumor immunity and its role in immunotherapy
Renren Yu et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2022)
CAR T cell killing requires the IFN gamma R pathway in solid but not liquid tumours
Rebecca C. Larson et al.
NATURE (2022)
Interferon-γ increases sensitivity to chemotherapy and provides immunotherapy targets in models of metastatic castration-resistant prostate cancer
Dimitrios Korentzelos et al.
SCIENTIFIC REPORTS (2022)
N-glycosylation Regulates Intrinsic IFN-γ Resistance in Colorectal Cancer: Implications for Immunotherapy
Julia Krug et al.
GASTROENTEROLOGY (2022)
STAT3 Inhibitors: A Novel Insight for Anticancer Therapy of Pancreatic Cancer
Xin Li et al.
BIOMOLECULES (2022)
UBR5 promotes tumor immune evasion through enhancing IFN-γ-induced PDL1 transcription in triple negative breast cancer
Bingbing Wu et al.
THERANOSTICS (2022)
Interferon-γ: teammate or opponent in the tumour microenvironment?
Angela M. Gocher et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma (vol 38, pg 500, 2020)
Catherine S. Grasso et al.
CANCER CELL (2021)
Blocking IFN. in CAR-T Reduces Checkpoint Inhibitors and Cell-Mediated Toxicity without Compromising Therapeutic Efficacy in CD19+malignancies
Stefanie R. Bailey et al.
BLOOD (2021)
Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response
Michelle von Locquenghien et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Interferon regulatory factor 1 (IRF1) and anti-pathogen innate immune responses
Hui Feng et al.
PLOS PATHOGENS (2021)
Interferon-γ induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation
Man Yu et al.
MOLECULAR CELL (2021)
USP22 deficiency in melanoma mediates resistance to T cells through IFNγ-JAK1-STAT1 signal axis
Min Li et al.
MOLECULAR THERAPY (2021)
Loss of Optineurin Drives Cancer Immune Evasion via Palmitoylation-Dependent IFNGR1 Lysosomal Sorting and Degradation
Wan Du et al.
CANCER DISCOVERY (2021)
Intrinsic Interferon Signaling Regulates the Cell Death and Mesenchymal Phenotype of Glioblastoma Stem Cells
Sabbir Khan et al.
CANCERS (2021)
A cross-talk between CAR T cell subsets and the tumor microenvironment is essential for sustained cytotoxic activity
Morgane Boulch et al.
SCIENCE IMMUNOLOGY (2021)
Serum IL-5 and IFN-γ Are Novel Predictive Biomarkers for Anti-PD-1 Treatment in NSCLC and GC Patients
Qiu Zhao et al.
DISEASE MARKERS (2021)
Novel interferon-sensitive genes unveiled by correlation-driven gene selection and systems biology
Cristina Cheroni et al.
SCIENTIFIC REPORTS (2021)
Interferon-γ liposome: a new system to improve drug delivery in the treatment of lung cancer
Maysa Alhawmdeh et al.
ERJ OPEN RESEARCH (2021)
IFN-γ-induced ER stress impairs autophagy and triggers apoptosis in lung cancer cells
Can Fang et al.
ONCOIMMUNOLOGY (2021)
Antitumor activity of the third generation EphA2 CAR-T cells against glioblastoma is associated with interferon gamma induced PD-L1
Zhijing An et al.
ONCOIMMUNOLOGY (2021)
The potential and controversy of targeting STAT family members in cancer
Yannick Verhoeven et al.
SEMINARS IN CANCER BIOLOGY (2020)
Interferon gamma inhibits CXCL8-CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer
Mingjie Zhang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapy
Jing Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
KLF7 promotes pancreatic cancer growth and metastasis by up-regulating ISG expression and maintaining Golgi complex integrity
Romi Gupta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
ZBED2 is an antagonist of interferon regulatory factor 1 and modifies cell identity in pancreatic cancer
Tim D. D. Somerville et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumours
Ellen Brenner et al.
NATURE COMMUNICATIONS (2020)
Loss of ELF5-FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signalling
Snahlata Singh et al.
NATURE CELL BIOLOGY (2020)
Changing the paradigm of IFN-γ at the interface between innate and adaptive immunity: Macrophage-derived IFN-γ
Soraya Mezouar et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2020)
High JAK2 Protein Expression Predicts a Poor Prognosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma
Yang Song et al.
DISEASE MARKERS (2020)
Prognostic Significance of Interferon-γ and Its Signaling Pathway in Early Breast Cancer Depends on the Molecular Subtypes
Anne-Sophie Heimes et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Roles of IFN-γ in tumor progression and regression: a review
Dragica Jorgovanovic et al.
BIOMARKER RESEARCH (2020)
Genomic and transcriptional changes in IFNγ pathway genes are putative biomarkers of response to ipilimumab immunotherapy in melanoma patients
Kristian Hargadon et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2020)
Safety and Efficacy of an Immune Cell-Specific Chimeric Promoter in Regulating Anti-PD-1 Antibody Expression in CAR T Cells
Yuan Fang et al.
Molecular Therapy-Methods & Clinical Development (2020)
Phase 1 dose-escalation study of momelotinib, a Janus kinase 1/2 inhibitor, combined with gemcitabine and nab-paclitaxel in patients with previously untreated metastatic pancreatic ductal adenocarcinoma
Kimmie Ng et al.
INVESTIGATIONAL NEW DRUGS (2019)
A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus nab-Paclitaxel and Gemcitabine in Advanced Solid Tumors
Gregory L. Beatty et al.
ONCOLOGIST (2019)
Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade
Chien-Chun Steven Pai et al.
IMMUNITY (2019)
Low-Dose IFNγ Induces Tumor Cell Stemness in Tumor Microenvironment of Non-Small Cell Lung Cancer
Mengjia Song et al.
CANCER RESEARCH (2019)
3-Deoxy-2β,16-dihydroxynagilactone E, a natural compound from Podocarpus nagi, preferentially inhibits JAK2/STAT3 signaling by allosterically interacting with the regulatory domain of JAK2 and induces apoptosis of cancer cells
Hui Shan et al.
ACTA PHARMACOLOGICA SINICA (2019)
Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III Interferons
Adriana Forero et al.
IMMUNITY (2019)
IFN-γ Promotes Epithelial-Mesenchymal Transition and the Expression of PD-L1 in Pancreatic Cancer
Daisuke Imai et al.
JOURNAL OF SURGICAL RESEARCH (2019)
IFN-γ down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+T-lymphocytes in pancreatic cancer
Guoping Ding et al.
BMC CANCER (2019)
Interferon target-gene expression and epigenomic signatures in health and disease
Franck J. Barrat et al.
NATURE IMMUNOLOGY (2019)
Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma
Hanjie Li et al.
CELL (2019)
The Interferon-Gamma Paradox in Cancer
M. Raza Zaidi
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2019)
Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss
Huayang Liu et al.
NATURE MEDICINE (2019)
JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression
Katie L. Owen et al.
CANCERS (2019)
Regulating IRFs in IFN Driven Disease
Caroline A. Jefferies
FRONTIERS IN IMMUNOLOGY (2019)
ERK is a negative feedback regulator for IFN-γ/STAT1 signaling by promoting STAT1 ubiquitination
Ying Zhang et al.
BMC CANCER (2018)
Ruxolitinib plus capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies
Herbert Hurwitz et al.
INVESTIGATIONAL NEW DRUGS (2018)
A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing
Deng Pan et al.
SCIENCE (2018)
Intratumoral Delivery of Interferonγ-Secreting Mesenchymal Stromal Cells Repolarizes Tumor-Associated Macrophages and Suppresses Neuroblastoma Proliferation In Vivo
Theresa Relation et al.
STEM CELLS (2018)
IFN-γ induces the upregulation of RFXAP via inhibition of miR-212-3p in pancreatic cancer cells: A novel mechanism for IFN-γ response
Guoping Ding et al.
ONCOLOGY LETTERS (2018)
The molecular basis of JAK/STAT inhibition by SOCS1
Nicholas P. D. Liau et al.
NATURE COMMUNICATIONS (2018)
Long-term G(1) cell cycle arrest in cervical cancer cells induced by co-immobilized TNF-alpha plus IFN-gamma polymeric drugs
Wuya Chen et al.
JOURNAL OF MATERIALS CHEMISTRY B (2018)
A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and type II IFN Responses
Agata Michalska et al.
FRONTIERS IN IMMUNOLOGY (2018)
Loss of IFN-γ pathway gene expression in tumor cells as mechanism of immune escape of colorectal carcinoma
Nathalie Britzen-Laurent et al.
CANCER RESEARCH (2018)
Interferon Gamma Inhibits CXCL8-Induced Proliferation and Migration of Pancreatic Cancer BxPC-3 Cell Line via a RhoGDI2/Rac1/NF-κB Signaling Pathway
Mingjie Zhang et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2018)
Protein Inhibitor of Activated STAT (PIAS) Negatively Regulates the JAK/STAT Pathway by Inhibiting STAT Phosphorylation and Translocation
Guo-Juan Niu et al.
FRONTIERS IN IMMUNOLOGY (2018)
Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients
Niki Karachaliou et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Interferon-γ Signaling in Melanocytes and Melanoma Cells Regulates Expression of CTLA-4
Xuan Mo et al.
CANCER RESEARCH (2018)
Current prospects of type II interferon signaling and autoimmunity
Daniel S. Green et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Identification of essential genes for cancer immunotherapy
Shashank J. Patel et al.
NATURE (2017)
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
Robert T. Manguso et al.
NATURE (2017)
Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity
Purnima Bhat et al.
CELL DEATH & DISEASE (2017)
Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions
Antje Sucker et al.
NATURE COMMUNICATIONS (2017)
Downregulation of A20 increases the cytotoxicity of IFN-gamma in hepatocellular carcinoma cells
Lei Yin et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
CD95/Fas Increases Stemness in Cancer Cells by Inducing a STAT1-Dependent Type I Interferon Response
Abdul S. Qadir et al.
CELL REPORTS (2017)
Post-translational modification of the interferon-gamma receptor alters its stability and signaling
James D. Londino et al.
BIOCHEMICAL JOURNAL (2017)
Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity
Abigail E. Overacre-Delgoffe et al.
CELL (2017)
Activating JAK1 mutation may predict the sensitivity of JAK-STAT inhibition in hepatocellular carcinoma
Shuqun Yang et al.
ONCOTARGET (2016)
Parsing the Interferon Transcriptional Network and Its Disease Associations
Sara Mostafavi et al.
CELL (2016)
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
Jianjun Gao et al.
CELL (2016)
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
Joseph L. Benci et al.
CELL (2016)
Metabolic Regulation of Natural Killer Cell IFN-γ Production
Annelise Y. Mah et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2016)
B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6
Shaun W. Jackson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer
K. Abiko et al.
BRITISH JOURNAL OF CANCER (2015)
Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed
Herbert I. Hurwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
Dongjun Peng et al.
NATURE (2015)
Interferon-gamma regulates cellular metabolism and mRNA translation to potentiate macrophage activation
Xiaodi Su et al.
NATURE IMMUNOLOGY (2015)
Antitumor potential of a synthetic interferon-alpha/PLGF-2 positive charge peptide hybrid molecule in pancreatic cancer cells
Hongmei Yin et al.
SCIENTIFIC REPORTS (2015)
High STAT1 mRNA levels but not its tyrosine phosphorylation are associated with macrophage infiltration and bad prognosis in breast cancer
Piotr Tymoszuk et al.
BMC CANCER (2014)
Combined inhibition of Notch and JAK/STAT is superior to monotherapies and impairs pancreatic cancer progression
Vindhya Palagani et al.
CARCINOGENESIS (2014)
Identification of IFN-γ-producing innate B cells
Yan Bao et al.
CELL RESEARCH (2014)
T-Cell and NK-Cell Infiltration into Solid Tumors: A Key Limiting Factor for Efficacious Cancer Immunotherapy
Ignacio Melero et al.
CANCER DISCOVERY (2014)
IFN-γ selectively exerts pro-apoptotic effects on tumor-initiating label-retaining colon cancer cells
Chao Ni et al.
CANCER LETTERS (2013)
Whole blood interferon- levels predict the therapeutic effects of adoptive T-cell therapy in patients with advanced pancreatic cancer
Takeshi Ishikawa et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Ubiquitin-Specific Protease 13 Regulates IFN Signaling by Stabilizing STAT1
Hom-Ming Yeh et al.
JOURNAL OF IMMUNOLOGY (2013)
Gamma Interferon Regulates Contraction of the Influenza Virus-Specific CD8 T Cell Response and Limits the Size of the Memory Population
Nayana Prabhu et al.
JOURNAL OF VIROLOGY (2013)
JAK1 truncating mutations in gynecologic cancer define new role of cancer- associated protein tyrosine kinase aberrations
Yuan Ren et al.
SCIENTIFIC REPORTS (2013)
Modulation of IFN-γ Receptor 1 Expression by AP-2α Influences IFN-γ Sensitivity of Cancer Cells
Changguo Chen et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Unphosphorylated STAT1 Promotes Sarcoma Development through Repressing Expression of Fas and Bad and Conferring Apoptotic Resistance
Mary A. Zimmerman et al.
CANCER RESEARCH (2012)
Prognostic significance of phosphorylated STAT-1 expression in premenopausal and postmenopausal patients with invasive breast cancer
Christina Magkou et al.
HISTOPATHOLOGY (2012)
Suppression of signal transducers and activators of transcription 1 in hepatocellular carcinoma is associated with tumor progression
Atsushi Hosui et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Autocrine IFN-γ Promotes Naive CD8 T Cell Differentiation and Synergizes with IFN-α To Stimulate Strong Function
Julie M. Curtsinger et al.
JOURNAL OF IMMUNOLOGY (2012)
Expression Signature of IFN/STAT1 Signaling Genes Predicts Poor Survival Outcome in Glioblastoma Multiforme in a Subtype-Specific Manner
Christine W. Duarte et al.
PLOS ONE (2012)
Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages
Xuefen Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The antagonistic effect between STAT1 and Survivin and its clinical significance in gastric cancer
Hao Deng et al.
ONCOLOGY LETTERS (2012)
Interferon γ improves the vaccination potential of oncolytic parvovirus H-1PV for the treatment of peritoneal carcinomatosis in pancreatic cancer
Svitlana P. Grekova et al.
CANCER BIOLOGY & THERAPY (2011)
Novel Engineered Targeted Interferon-gamma Blocks Hepatic Fibrogenesis in Mice
Ruchi Bansal et al.
HEPATOLOGY (2011)
Cooperative contributions of Interferon regulatory factor 1 (IRF1) and IRF8 to interferon-γ-mediated cytotoxic effects on oligodendroglial progenitor cells
Makoto Horiuchi et al.
JOURNAL OF NEUROINFLAMMATION (2011)
NF-κB Protects Cells from Gamma Interferon-Induced RIP1-Dependent Necroptosis
Roshan J. Thapa et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
A diverse range of gene products are effectors of the type I interferon antiviral response
John W. Schoggins et al.
NATURE (2011)
Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells
Gregory B. Lesinski et al.
BMC CANCER (2010)
Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanoma
Stefanie Meyer et al.
EXPERIMENTAL DERMATOLOGY (2010)
Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer
N. Khodarev et al.
ONCOGENE (2010)
IFN-γ-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer
Matteo Martini et al.
VACCINE (2010)
Clinical Use of Interferon-gamma
Catriona H. T. Miller et al.
CYTOKINE THERAPIES: NOVEL APPROACHES FOR CLINICAL INDICATIONS (2009)
Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival
Jonathan R. Brody et al.
CELL CYCLE (2009)
A phosphorylation-acetylation switch regulates STAT1 signaling
Oliver H. Kraemer et al.
GENES & DEVELOPMENT (2009)
Secretion of interferon-γ by human macrophages demonstrated at the single-cell level after costimulation with interleukin (IL)-12 plus IL-18
Laila Darwich et al.
IMMUNOLOGY (2009)
A ChIPchip approach reveals a novel role for transcription factor IRF1 in the DNA damage response
Mattia Frontini et al.
NUCLEIC ACIDS RESEARCH (2009)
Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes
HyeonJoo Cheon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Negative feedback regulation of IFN-γ pathway by IFN regulatory factor 2 in esophageal cancers
Yan Wang et al.
CANCER RESEARCH (2008)
Natural Killer Cell Accumulation in Tumors Is Dependent on IFN-γ and CXCR3 Ligands
Marco Wendel et al.
CANCER RESEARCH (2008)
Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: Results from a prospectively designed analysis of progression-free survival
David S. Alberts et al.
GYNECOLOGIC ONCOLOGY (2008)
被撤回的出版物: ERK and the F-box protein βTRCP target STAT1 for degradation (Retracted article. See vol. 293, pg. 4954, 2018)
Surinder M. Soond et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Combination of all-trans retinoic acid and interferon-gamma suppressed PI3K/Akt survival pathway in glioblastoma T98G cells whereas NF-κB survival signaling in glioblastoma U87MG cells for induction of apoptosis
Ran Zhang et al.
NEUROCHEMICAL RESEARCH (2007)
IFN-γ-induced expression of MUC4 in pancreatic cancer cells is mediated by STAT-1 upregulation:: a novel mechanism for IFN-γ response
M. Andrianifahanana et al.
ONCOGENE (2007)
Influence of IFN-gamma and its receptors in human breast cancer
Ignacio Garcia-Tunon et al.
BMC CANCER (2007)
Direct interferon-γ signalling and CD8+ T cell memory
Jason K. Whitmire et al.
JOURNAL OF IMMUNOLOGY (2007)
IFN-γ mediates CD4+ T-cell loss and impairs secondary antitumor responses after successful initial immunotherapy
Vanessa Berner et al.
NATURE MEDICINE (2007)
IFN-γ and its receptor subunit IFNGR1 are recruited to the IFN-γ-activated sequence element at the promoter-site of IFN-γ-activated genes:: Evidence of transactivational activity in IFNGR1
CMI Ahmed et al.
JOURNAL OF IMMUNOLOGY (2006)
REFINEMENT: A search framework for the identification of interferon-responsive elements in DNA sequences - a case study with ISRE and GAS
T Tsukahara et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2006)
Identification of GAS-dependent interferon-sensitive target genes whose transcription is STAT2-dependent but ISGF3-independent
MM Brierley et al.
FEBS JOURNAL (2006)
Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis
SC Xi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
A novel dendritic cell subset involved in tumor immunosurveillance
J Taieb et al.
NATURE MEDICINE (2006)
Production of interferon-gamma by myeloid cells - fact or fancy?
C Bogdan et al.
TRENDS IN IMMUNOLOGY (2006)
Strong HLA-DR antigen expression on cancer cells relates to better prognosis of colorectal cancer patients: Possible involvement of c-myc suppression by interferon-gamma in situ
K Matsushita et al.
CANCER SCIENCE (2006)
Regulation of IFN-γ production by B effector 1 cells:: Essential roles for T-bet and the IFN-γ receptor
DP Harris et al.
JOURNAL OF IMMUNOLOGY (2005)
Mechanisms of type-I- and type-II-interferon-mediated signalling
LC Platanias
NATURE REVIEWS IMMUNOLOGY (2005)
Interferon-γ acts directly on CD8+ T cells to increase their abundance during virus infection
JK Whitmire et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-γ-induced HLA-DR expression in colorectal and gastric cancer cells
A Satoh et al.
ONCOGENE (2004)
Interferon-γ is an autocrine mediator for dendritic cell maturation
JP Pan et al.
IMMUNOLOGY LETTERS (2004)
Amplification of IFN-α-induced STAT1 activation and inflammatory function by Syk and ITAM-containing adaptors
I Tassiulas et al.
NATURE IMMUNOLOGY (2004)
IFN-γ enhances TRAIL-induced apoptosis through IRF-1
SY Park et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2004)
Different levels of control prevent interferon-γ-inducible HLA-class II expression in human neuroblastoma cells
M Croce et al.
ONCOGENE (2003)
Chimeric TNT-3 antibody/murine interferon-γ fusion protein for the immunotherapy of solid malignancies
MM Mizokami et al.
HYBRIDOMA AND HYBRIDOMICS (2003)
The role of IFNγ nuclear localization sequence in intracellular function
CML Ahmed et al.
JOURNAL OF CELL SCIENCE (2003)
IFNγ sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway
S Fulda et al.
ONCOGENE (2002)
Lack of IFN-γ-mediated induction of the class II transactivator (CIITA) through promoter methylation is predominantly found in developmental tumor cell lines
N van der Stoep et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Interferon-γ reduces melanosomal antigen expression and recognition of melanoma cells by cytotoxic T cells
IC Le Poole et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-γ-dependent suppression of subcutaneous tumor growth
K Takeda et al.
CELLULAR IMMUNOLOGY (2001)
Regulation of IFN-γ signaling is essential for the cytotoxic activity of CD8+ T cells
GZ Tau et al.
JOURNAL OF IMMUNOLOGY (2001)
Nuclear translocation of IFN-γ is an intrinsic requirement for its biologic activity and can be driven by a heterologous nuclear localization sequence
PS Subramaniam et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2001)
Interferon γ inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis
KM Detjen et al.
GUT (2001)
IFN-γ can promote tumor evasion of the immune system in vivo by down-regulating cellular levels of an endogenous tumor antigen
GL Beatty et al.
JOURNAL OF IMMUNOLOGY (2000)
Synergistic induction of the Tap-1 gene by IFN-γ and lipopolysaccharide in macrophages is regulated by STAT1
LA Cramer et al.
JOURNAL OF IMMUNOLOGY (2000)
Differential nuclear localization of the IFNGR-1 and IFNGR-2 subunits of the IFN-γ receptor complex following activation by IFN-γ
J Larkin et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2000)
Share Paper
